# Guanfacine to Treat Borderline Personality Disorder

> **NCT00358969** · NA · UNKNOWN · sponsor: **Icahn School of Medicine at Mount Sinai**

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DRUG:** guanfacine (Tenex)

## Key facts

- **NCT ID:** NCT00358969
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358969, "Guanfacine to Treat Borderline Personality Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00358969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*